Seres Therapeutics
Seres Therapeutics is a late-clinical-stage biotechnology company dedicated to developing microbiome-based therapeutics for serious diseases linked to microbial imbalances. Founded in 2011 and publicly traded on NASDAQ under the ticker MCRB, the company utilizes its Ecobiotic® platform to create live bacterial consortia aimed at restoring healthy microbiome function. The company focuses on tre...
N/A
Technology
2010
Founded
190
Employees
research
Industry
Visual (Placeholder)
Profile Information
Name
Seres Therapeutics
Industry
research
Technology
N/A
Location
N/A
Founded
2010
Employees
190
Category
Partner